← Back
Tyra Biosciences
TYRA · listed on Nasdaq · worth $1.42 billion
$21.37
+0.19% on Nov 3
One insider buy in the last year, $20K in all. None in the last two weeks.
Different buyers at onceDirector Rehan Verjee bought, and Paradigm Biocapital Advisors LP reported a new 5.8% stake, within 6 days · Sep 17
Green dot = an insider bought red = sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
34.7M shares
50% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought Tyra Biosciences stock and two insiders sold. None of the 13 sales is marked on its filing as planned in advance; most by company executives. The biggest seller was Robert J. More.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
Director
Rehan Verjee
Bought $20K on Sep 9 — 972 shares at $20.58, 100% of what they now own.
First purchase we have on file
Big investors
People and funds that reported owning 5% or more of Tyra Biosciences, newest first.
Filed by someone who owns 5% or more and does not plan to influence the company.Biotechnology Value Fund L P3.2%Sep 21
Filed by someone who owns 5% or more and may try to influence how the company is run. · updateRA Capital Management19.9%Sep 17
Filed by someone who owns 5% or more and does not plan to influence the company.Paradigm Biocapital Advisors LP5.8%Sep 17
All reports
Every insider trade and SEC report we hold for Tyra Biosciences.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
20 more with Pro →Analysts, earnings and news
Analysts' price target
$49.40 average
10 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
2 of 5 quarters above
Q2 '26−$0.69 a share−$0.05
Q1 '26−$0.64 a share−$0.05
Q4 '25−$0.57 a share−$0.04
Q3 '25−$0.50 a share+$0.01